GLP-1 meaning in plain English: from gut hormone to weekly injection
GLP-1 abbreviates glucagon-like peptide-1, a hormone the intestine sends out at mealtimes. Those four characters have also become the everyday nickname for a family of prescription drugs, Ozempic® and Zepbound® among them, built to imitate it. This entry pulls the two senses apart and decodes the vocabulary that travels with them.
Key points
- Full name: glucagon-like peptide-1, a natural gut hormone.1
- Job: lowering blood sugar after food and acting on the brain’s appetite controls.1
- Lifespan: a half-life near 1.5 to 2 minutes.2
- Medicines: longer-lived mimics known as GLP-1 receptor agonists.1
What is GLP-1 short for?
GLP-1 stands for glucagon-like peptide-1, read aloud as “G-L-P one.” Every piece of the name tells you something.
- Glucagon-like. The body carves GLP-1 out of proglucagon, the parent molecule that also yields glucagon. The kinship is chemical only. GLP-1 actually suppresses glucagon release.3
- Peptide. Chemists use the word for a short chain of amino acids, typically 2 to 50 links long.4 GLP-1 has 30.3
- 1. A sibling, GLP-2, exists. A GLP-2 drug called Gattex treats short bowel syndrome, an unrelated condition.5
Hormone or drug? The two senses of “GLP-1”
In a physiology textbook the term names the hormone. At a pharmacy counter or in a headline it nearly always names a medicine. The official class name is GLP-1 receptor agonists, shortened to GLP-1 RAs: medicines that mimic the hormone.1 An agonist is a compound that binds to a receptor and activates it,6 so these drugs press the button natural GLP-1 presses.
| What you hear | What is meant |
|---|---|
| “My sister started a GLP-1.” | She takes a medicine from the class, perhaps Wegovy® or Mounjaro®. |
| “GLP-1 agonist” | The same medicines, by their formal name. |
| “GIP/GLP-1” or “dual agonist” | Tirzepatide, which works on a second receptor as well.1 |
| “Oral GLP-1” | A tablet form, such as the Wegovy pill or Foundayo.7,8 |
How does GLP-1 work inside the body?
It manages the aftermath of a meal. Food reaching the gut prompts cells in the intestinal lining to release the hormone,3 which then acts at three sites.
| Site | Action | Result |
|---|---|---|
| Pancreas | Stimulates insulin secretion and restrains glucagon3 | Blood sugar climbs less after eating1 |
| Digestive tract | Slows the movement of food through the gut3 | A meal stays with you longer |
| Brain | Works on regions that control appetite and food intake1 | Hunger eases |
The insulin signal is conditional. GLP-1 calls for insulin when glucose is high, as it is just after a meal.9 Semaglutide keeps that trait: its label describes a glucose-dependent effect on insulin and flags low blood sugar mainly for people who combine it with insulin or a sulfonylurea.10
The stomach effect carries over to the medicines too. Tirzepatide’s label notes that the delay in stomach emptying is largest after the first dose and fades with time.6
Why can’t natural GLP-1 do what the drugs do?
It disappears too quickly. The body’s own supply survives only 1.5 to 2 minutes (its half-life) before the enzyme DPP-4 takes it apart,2 some of it before the hormone has even left the gut.3 That is ample for one dinner and useless for a week.
Drug designers reworked the molecule to survive. Semaglutide matches human GLP-1 in 94% of its sequence yet clings to albumin, a blood protein, which stretches its half-life to roughly 1 week.10 Tirzepatide’s is about 5 days.6 Hence one dose a week for each.
What are GLP-1 medications?
They are prescription drugs that switch on the GLP-1 receptor. The FDA treats them as a single class, used widely for type 2 diabetes and for reducing excess body weight, with extra approvals in some cases for heart, kidney, liver or sleep apnea conditions.1

| Brand | Active ingredient | Form | Main FDA-approved use |
|---|---|---|---|
| Ozempic | Semaglutide | Weekly injection | Type 2 diabetes10 |
| Wegovy | Semaglutide | Weekly injection or daily tablet | Weight reduction7 |
| Mounjaro | Tirzepatide | Weekly injection | Type 2 diabetes11 |
| Zepbound | Tirzepatide | Weekly injection | Weight reduction; obstructive sleep apnea with obesity6 |
| Foundayo | Orforglipron | Daily tablet | Weight reduction8 |
Uses are abbreviated from each label. The FDA’s class list also names Saxenda and Victoza (liraglutide), Trulicity (dulaglutide) and generic exenatide.1 Neither Ozempic nor Mounjaro has a weight loss approval. Both are diabetes medicines, so a weight loss prescription for one of them counts as off-label use.
A short history of GLP-1 drugs
- 2005: Byetta (exenatide) becomes the first approved GLP-1 RA.1 Exenatide is a synthetic version of exendin-4, a peptide discovered in the venom of the Gila monster lizard.9
- 2010 to 2014: liraglutide (Victoza, then Saxenda) and dulaglutide (Trulicity) follow.1
- 2017 and 2021: semaglutide arrives as Ozempic, later as Wegovy.1
- 2022 and 2023: tirzepatide launches as Mounjaro, then Zepbound.1
- April 1, 2026: Foundayo wins approval as a once-a-day pill with no empty-stomach rule.8
Uptake has been fast. When KFF polled the public in late 2025, nearly one adult in five (18%) reported ever using a GLP-1 drug, and 12% were on one at the time.12
GLP-1 for weight loss: what the term means there
When the subject is weight, “a GLP-1” is one of these medicines prescribed to bring body weight down. People taking them eat fewer calories, an effect the Wegovy label says is probably driven by appetite.7
None is intended for shedding a few vanity pounds. Wegovy, Zepbound and Foundayo are approved for adults who have obesity, and for adults who are overweight and have one or more weight-related conditions, always paired with a lower-calorie diet and added physical activity.6,7,8 Our BMI calculator shows which category you are in.
Two trials anchor expectations. STEP 1 gave 1,961 adults semaglutide 2.4 mg weekly or placebo for 68 weeks, and average weight fell 14.9% versus 2.4%.13 SURMOUNT-1 tested tirzepatide 5, 10 and 15 mg in 2,539 adults for 72 weeks, with average falls of 15.0%, 19.5% and 20.9% versus 3.1% on placebo.14 These are group averages earned alongside diet and exercise support. Individuals landed well above and below them.
GLP-1 vs. GIP/GLP-1: where does tirzepatide fit?
Halfway in. Tirzepatide hits a pair of receptors: the GLP-1 receptor, plus the receptor for a second natural hormone, GIP (glucose-dependent insulinotropic polypeptide).6 The FDA files it with the GLP-1 RAs and adds a footnote.1 Semaglutide acts on GLP-1 alone.
Each medicine has its own page: Wegovy, Zepbound, Ozempic, Mounjaro, compounded semaglutide and compounded tirzepatide. Compounded versions have no FDA approval, and the agency does not vet their safety, effectiveness or quality.15
GLP-1 glossary: the vocabulary, A to Z
Fifteen words and abbreviations that turn up in clinics, on insurance forms and in the news.
| Word | What it means |
|---|---|
| A1C | A blood test reflecting average blood sugar across the past 3 months.16 |
| Agonist | A compound that binds to a receptor and activates it.6 |
| BMI | Body mass index: weight in kilograms divided by height in meters squared.17 |
| Compounded | Mixed by a pharmacy for one patient’s prescription. Such products are not FDA-approved, and the agency checks neither their safety nor their effectiveness nor their quality.15 |
| DPP-4 | The enzyme that destroys natural GLP-1.2 DPP-4 inhibitors are a different family of diabetes drugs.1 |
| GIP | Glucose-dependent insulinotropic polypeptide, the natural hormone behind tirzepatide’s second target.1,6 |
| GLP-1 RA | Short for GLP-1 receptor agonist, the class name regulators use.1 |
| Half-life | The time the body needs to clear half of a substance: minutes for natural GLP-1, about a week for semaglutide.2,10 |
| Incretin | Any hormone from the gut that raises insulin output after a meal. GLP-1 is one.3 |
| Maintenance dose | The dose you remain on once the step-ups end. |
| Off-label | Use of an approved drug for a purpose the FDA has not approved, Ozempic for weight loss being one example.18 |
| Prior authorization | A health plan’s approval, sometimes required before it will cover a prescription.19 |
| Semaglutide | The ingredient inside Ozempic and Wegovy. |
| Tirzepatide | The ingredient inside Mounjaro and Zepbound. |
| Titration | Raising a dose in stages. Weekly injections generally step up every 4 weeks.6,7 |
What GLP-1 is not
Five confusions account for most of the wrong answers online.
GLP-1 is not insulin
An insulin injection supplies the hormone directly. A GLP-1 medicine nudges the pancreas to release its own, and chiefly while blood sugar is elevated.10
GLP-1 is not a stimulant
Phentermine, a different kind of weight loss drug, is a sympathomimetic amine chemically related to amphetamine.20 GLP-1 medicines belong to another category entirely: they act through a hormone receptor.
GLP-1 is not a synonym for Ozempic
The Ozempic brand covers a single ingredient, semaglutide. The class holds several ingredients sold under many names, each with its own approved uses.
“GLP-1” supplements, patches and drops are not GLP-1 medications
All the approved medicines in the table above require a prescription. The FDA has warned about counterfeit Ozempic and about products sold online as “for research purposes” or “not for human consumption.”15 Anything bought with no prescription is not one of the drugs described here.
Can you raise GLP-1 naturally?
Yes, by eating: meals trigger its release.3 The surge is gone within minutes, though, which is one reason diet by itself does not behave like a weekly injection.
GLP-1 side effects and safety, in brief
Mostly digestive and mostly early. On Wegovy 2.4 mg, 44% of adults reported nausea (placebo: 16%). On Zepbound the figure ran from 25% to 29% depending on dose (placebo: 8%).6,7 Vomiting, diarrhea and constipation are frequent too, and with Zepbound most of these episodes came while doses were rising and eased over time.6
Rarer and more serious problems include pancreatitis, gallbladder disease and kidney injury brought on by dehydration.7 In November 2026 the FDA said labels must also warn of a potential increased risk of NAION, an uncommon cause of sudden vision loss in one eye.1 The labels for semaglutide, tirzepatide and orforglipron each open with a boxed warning, the subject being thyroid C-cell tumors,6,7,8 summarized in the safety information. Frequencies and warning signs are covered in our GLP-1 side effects guide.
Is a GLP-1 medicine suitable for you? How to check
Someone licensed to prescribe has to look at your health history. At AM Rx that begins with an online questionnaire, which a licensed provider reviews before replying by secure message. No live appointment is needed to begin.
For a brand-name prescription, the prior authorization paperwork is handled by our insurance coordinators, and a monthly copay as low as $25 is possible when your plan covers the drug. Month one of AM Rx membership costs $39 and each later month costs $135, medication not included.
GLP-1 meaning: questions and answers
Does GLP-1 refer to a hormone or to a medicine?
Either, depending on who is speaking. Biologists mean the hormone your intestine releases after food. Patients, pharmacists and reporters usually mean a medicine that imitates it, formally a GLP-1 receptor agonist.1 Anyone who says they are “on a GLP-1” is talking about the medicine.
Why is it called glucagon-like if it lowers blood sugar?
The name records its origin, not its effect. GLP-1 is produced from proglucagon, the molecule that also gives rise to glucagon, and the name reflects that shared origin. Functionally it runs the other way: it stimulates insulin and inhibits glucagon secretion.3
What does the RA in GLP-1 RA mean?
Receptor agonist. A receptor is the docking site a hormone uses on a cell, and an agonist is a substance that binds there and activates it. A GLP-1 RA is therefore a medicine built to activate the same receptor the natural hormone uses, only for far longer.1,6
Is Ozempic a GLP-1?
Yes. Ozempic contains semaglutide, a GLP-1 receptor agonist given once a week. Its FDA approval covers adults with type 2 diabetes and does not extend to weight loss, so using it for weight is off-label.10 Wegovy contains the same ingredient and does carry a weight indication.7
Does GLP-1 mean the same thing as semaglutide?
No. Semaglutide is one member of the GLP-1 class, sold as Ozempic and Wegovy. The class also includes tirzepatide, liraglutide, dulaglutide, exenatide and orforglipron, each a separate ingredient with its own brands and approved uses.1 Calling all of them “semaglutide” is like calling every car a sedan.
How long does natural GLP-1 last in the body?
A couple of minutes. Drug labels put the half-life of the body’s own GLP-1 at 1.5 to 2 minutes, the work of the enzyme DPP-4.2 Semaglutide, by comparison, has a half-life of about 1 week,10 which is what makes a once-weekly dose possible.
Are all GLP-1 medications injections?
No. Wegovy also comes as a daily tablet, swallowed on an empty stomach with a small amount of water,7 and Foundayo is a once-a-day pill with no food restrictions.8 Most others, Ozempic, Zepbound and Mounjaro included, are weekly shots given just beneath the skin.
Was the first GLP-1 drug really based on lizard venom?
In a sense, yes. Researchers found a peptide named exendin-4 in Gila monster venom that resembled human GLP-1 but stayed active for hours. Exenatide, a synthetic form of it, was then developed for type 2 diabetes and sold as Byetta.9 Today’s leading drugs are different molecules.
What is the difference between GLP-1 and GIP?
They are two separate hormones made by the body, and each has a receptor of its own. GIP stands for glucose-dependent insulinotropic polypeptide. Semaglutide targets the GLP-1 receptor only, while tirzepatide (Zepbound, Mounjaro) activates the GIP and GLP-1 receptors together.6 The FDA still lists tirzepatide with the GLP-1 class.1
Is compounded semaglutide a GLP-1?
It is a pharmacy-prepared product made with a GLP-1 ingredient, but it should not be confused with Ozempic or Wegovy. No FDA approval stands behind compounded drugs, and the agency does not assess how safe, effective or well made they are.15 A licensed provider judges whether one suits you.
Important safety information for GLP-1 medicines
A class-level summary drawn from the Ozempic, Wegovy, Mounjaro and Zepbound labels.6,7,10,11 Each drug’s own prescribing information is the full reference.
Boxed warning: risk of thyroid C-cell tumors
Semaglutide and tirzepatide cause thyroid C-cell tumors in rodents. Nobody knows whether they cause such tumors, medullary thyroid carcinoma (MTC) included, in humans. These medicines are off limits for anyone with a personal or family history of MTC, or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report a lump in the neck, hoarseness, trouble swallowing or shortness of breath.
Do not use if
- you or a relative has had MTC, or you have MEN 2
- you have had a serious allergic reaction to the drug or its ingredients
Serious risks
- Pancreatitis: stop and seek care for severe abdominal pain that persists, with or without vomiting.
- Gallbladder problems, gallstones among them.
- Low blood sugar, particularly alongside insulin or a sulfonylurea.
- Kidney injury after fluid loss from vomiting or diarrhea.
- Severe stomach and bowel reactions; not recommended with severe gastroparesis.
- Serious allergic reactions: swelling of the face or throat, or difficulty breathing.
- Vision: worsening diabetic retinopathy in people with type 2 diabetes, and a potential increased risk of NAION.1
- Aspiration under anesthesia: tell your surgical team before any procedure with sedation.
Most common side effects
Nausea, diarrhea, vomiting, constipation and abdominal pain.
Pregnancy and birth control
Wegovy should be stopped at least 2 months before a planned pregnancy.7 Tirzepatide can make birth control pills less effective, so a non-oral or barrier method is advised for 4 weeks after starting and after each dose increase.6
Sources
- FDA. FDA requires safety labeling changes for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) due to potential increased risk of rare but serious eye condition. Drug Safety Communication. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
- Saxenda (liraglutide) injection. Prescribing Information. Novo Nordisk. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
- Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-1439. https://pubmed.ncbi.nlm.nih.gov/17928588/
- National Human Genome Research Institute. Talking glossary: peptide. https://www.genome.gov/genetics-glossary/Peptide
- Gattex (teduglutide) for injection. Prescribing Information. Takeda. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66b69c1e-b25c-44d3-b5ff-1c1de9a516fa
- Zepbound (tirzepatide). Prescribing Information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
- Wegovy (semaglutide) injection and tablets. Prescribing Information. Novo Nordisk. Revised June 2026. https://www.novo-pi.com/wegovy.pdf
- FDA. FDA approves first new molecular entity under National Priority Voucher program (Foundayo). April 1, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program
- National Institute on Aging. Exendin-4: from lizard to laboratory...and beyond. July 11, 2012. https://www.nia.nih.gov/news/exendin-4-lizard-laboratory-and-beyond
- Ozempic (semaglutide) injection. Prescribing Information. Novo Nordisk. Revised May 2026. https://www.novo-pi.com/ozempic.pdf
- Mounjaro (tirzepatide). Prescribing Information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
- KFF. KFF Health Tracking Poll: prescription drug costs, views on Trump administration actions, and GLP-1 use. November 14, 2025. https://www.kff.org/public-opinion/kff-health-tracking-poll-prescription-drug-costs-views-on-trump-administration-actions-and-glp-1-use/
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
- FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- National Institute of Diabetes and Digestive and Kidney Diseases. The A1C test and diabetes. https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test
- Centers for Disease Control and Prevention. BMI frequently asked questions. https://www.cdc.gov/bmi/faq/index.html
- FDA. Understanding unapproved use of approved drugs “off label.” https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label
- HealthCare.gov. Glossary: prior authorization. https://www.healthcare.gov/glossary/prior-authorization/
- Phentermine hydrochloride. Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f115ad6d-cf62-40e7-89d1-6183a9b5071f
Check a GLP-1 medicine against your own health history
The health questionnaire takes a few minutes and is read by a licensed provider. Your first month of AM Rx membership is $39.

Past the definition: a provider’s view of your case
A glossary can explain a drug class. Only a licensed provider who has read your health history can say whether one of these medicines belongs in your treatment.
The AM Rx care team checks the medical content of this page against FDA prescribing information and published clinical trials. It is general health education and does not replace advice from your own provider.
AM Rx members on getting started
One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
I started semaglutide at the recommendation of my AM Rx provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and AM Rx was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Since I started AM Rx, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Individual results may vary. These reviews describe the experience of individual AM Rx members and do not promise any result. Medication is prescribed only if a licensed provider considers it appropriate.
The GLP-1 medications AM Rx providers prescribe
Four brand-name medications and two compounded options. Which one you are offered depends on your health history and a licensed provider’s judgment, and our insurance coordinators file the prior authorization when a brand-name drug is prescribed.
Zepbound®
Weekly tirzepatide. FDA-approved for chronic weight management and for obstructive sleep apnea in adults with obesity.
Zepbound cost, coupons and side effects →Wegovy®
Semaglutide for chronic weight management, FDA-approved as a weekly injection and as a once-daily tablet.
Wegovy pill, price and side effects →Mounjaro®
Weekly tirzepatide with an FDA approval for type 2 diabetes. It shares its active ingredient with Zepbound.
Mounjaro doses and savings card →Ozempic®
Weekly semaglutide with an FDA approval for type 2 diabetes. Using it for weight loss is off-label.
Ozempic side effects and cost →Compounded semaglutide
$199 a month, or from $106 a month when you order a 3-month supply. Shipping is included. Not FDA-approved.
Semaglutide cost and dosing →Compounded tirzepatide
$329 a month, or from $216 a month when you order a 3-month supply. Shipping is included. Not FDA-approved.
Tirzepatide dosage and cost →A partner pharmacy prepares compounded medication for one patient’s prescription at a time. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality. AM Rx membership costs $39 for the first month and $135 a month after that, and is charged separately from medication. Nothing is prescribed unless a licensed provider finds it appropriate.